Menu
AI-driven solutions, aiming to save costs and lives through early detection
Prevalence of Lung Cancer
Optimizing Screening Workflows for Faster Diagnosis
Lung cancer remains one of the leading causes of cancer-related deaths globally. With one in two individuals likely to face a cancer diagnosis in their lifetime, lung cancer stands as a critical public health challenge. Early and effective diagnosis through innovative screening technologies is crucial to improving outcomes and survival rates, necessitating significant advancements in diagnostic methods.
Lung cancer is often diagnosed at an advanced stage, which drastically reduces survival rates. ChestClearAI aims to change that by enabling earlier detection through AI-powered screening tools. By identifying subtle patterns in imaging data that may be missed in manual reviews, ChestClearAI facilitates quicker and more accurate diagnosis, giving patients a better chance at timely treatment and improved outcomes.
The global shortage of radiologists is exacerbating the pressure on existing professionals, contributing to burnout and reducing the overall efficiency of cancer screening programs. ChestClearAI alleviates this burden by automatically identifying and filtering out normal cases, allowing radiologists to focus on abnormal or suspicious cases. This approach enhances productivity, improves accuracy, and reduces the mental and physical strain on radiologists.
Traditional screening methods are often slow, leading to high turnaround times and delays in treatment. With ChestClearAI, screening workflows are optimized to ensure faster and more consistent results. The AI’s ability to process large volumes of data quickly and accurately helps reduce bottlenecks in the diagnostic process, enabling earlier intervention and improving overall patient outcomes.
Boost of accuracy through AI by reducing human error
Turnaround time improved by c. 30%
Round 1
Nov 2021
Dec 2022
Awarded 1st place TIE Women’s London Chapter
Dec 2022
Mar 2022
Mar 2022
Awarded spot in the highly selective healthtech accelerator programme
Mar 2023
Round 2
Jan 2023
RTO catapult grant
Mar 2023
MaRS Accelerator Program
Mar 2024
Advance Tier 1 IP Audit Grant
Sep 2024
FIND OUT WHAT’S HAPPENING
